Clorox has fully recovered from its August 2023 cyberattack but faced headwinds from macroeconomic uncertainties and category slowdowns in the latter half of fiscal 2025.
The company's operational recovery from the cyberattack demonstrates resilience, but the acknowledgment of macroeconomic pressures affecting consumer behavior signals ongoing challenges. The divestiture of its vitamins and supplements brands (Natural Vitality, RenewLife, NeoCell, and Rainbow Light) suggests portfolio optimization efforts, while the workforce reduction from 8,000 to 7,600 employees indicates cost management initiatives.
Clorox showed strong cash generation with operating cash flow increasing meaningfully to $981 million, reflecting improved operational efficiency post-cyberattack recovery. However, the company reduced inventory levels by 18% while current liabilities grew substantially, suggesting tighter working capital management. The modest decline in cash and equivalents combined with higher liabilities indicates active capital deployment, likely supporting the portfolio restructuring and operational improvements.
Operating cash flow surged 41.2% — exceptional cash generation, highest quality earnings signal.
Current liabilities rose 21.9% — increased short-term obligations, watch current ratio.
Inventory reduced 17.9% — lean inventory management or demand outpacing supply.
Cash decreased 17.3% — monitor burn rate and upcoming capital needs.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →